NCT05822193 Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
| NCT ID | NCT05822193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inova Medical |
| Condition | Post-Acute COVID-19 Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,694 participants |
| Start Date | 2023-07-21 |
| Primary Completion | 2025-07-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Brazilian resident; * Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment. Exclusion Criteria: * No availability to participate in remote research appointments; * Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia) * Refuse to provide informed consent
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.